Congress Materials – Alzheimer's and Parkinson's Disease Conference (ADPD 2026)
2026 Alzheimer's and Parkinson's Disease Conference | Apr 17-21 | Copenhagen, Denmark
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Results from the Phase 2b AutonomyTrial of Anti-p-tau Monoclonal Antibody Posdinemab for Early Alzheimer’s Disease
Sharon Cohen, Stephen Salloway, David Watson, Reisa Sperling, Ziad S. Saad, Maggie Fedgchin, Jennifer Bogert, Pieter-Jan Berghmans, David Henley, Lingjue Li, Gallen Triana-Baltzer, Serge Van der Geyten, Haiyan Xu, Arthur Simen, Fiona Elwood, Janice Wong
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.